CORRIGAN MARK 4
4 · NOVELION THERAPEUTICS INC. · Filed Aug 13, 2018
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-08-09+50,000→ 50,000 totalExercise: $3.33Exp: 2028-08-09→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]The option shall vest in twelve equal monthly installments, beginning one month after the grant date.